Experts in AI-Powered lung image analysis
Advancing pulmonary precision medicine
Our Technology
- State-of-the-art segmentation and quantification capabilities for high-precision assessment of lung structures and disease patterns
- Wide portfolio of AI measurement and analytical capabilities tailored to clinically-relevant use cases
- Consistently high performance, extensively validated across diseases and patient populations
Solutions
We apply our expertise to transform cutting-edge technology into real-world impact, supporting our partners in developing novel and advanced therapies.
Powering minimally invasive
pulmonary interventions
AI-enabled imaging technology for next-generation bronchoscopic and surgical procedures
Advancing clinical trials for
pharmaceutical drug development
Quantitative CT analysis and treatment efficacy assessment for imaging-based respiratory trials
Proven across all major lung diseases and therapeutic areas:
Ready to see how we can accelerate your innovation?
Let’s advance precision medicine together!
Why Thirona
Knowledge & Expertise
Strong scientific backbone and unmatched domain expertise in thoracic imaging, backed by proven clinical implementations.
Quality & Performance
State-of-the-art AI technology with rigorous validation and quality assurance, delivered under full regulatory compliance.
Service & Reliability
Reliable and trusted project delivery, with a strong commitment to customer success, and simply a great team to work with.
Trusted by industry and clinical research leaders
Fibrotic and vascular abnormalities quantified by an AI-based model are associated with outcomes in patients with idiopathic pulmonary fibrosis
Effect of elexacaftor–tezacaftor–ivacaftor on bronchial dilatations in adolescents with cystic fibrosis: a multicentre prospective observational study
